Akb-6548-Ci-0017
ClinicalTrials.gov NCT02892149
Research payments
$4,341,686
Through program year 2021, $4,341,686 in research payments was reported against Akb-6548-Ci-0017, across 9,688 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- NCT02892149
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $4,341,686 | 9,688 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Roberto Manllo-Karim McAllen, TX Named on 1,694 payments
- Jesus Navarro Tampa, FL Named on 1,508 payments
- Margaret Cook Austin, TX Named on 901 payments
- Amarnath Kathresal Durham, NC Named on 702 payments
- Mark Boiskin San Diego, CA Named on 629 payments
- Angela Riley Columbus, MS Named on 558 payments
- Pablo Pergola San Antonio, TX Named on 299 payments
- Donovan Polack Saint Louis, MO Named on 278 payments
- Arnold Silva Meridian, ID Named on 257 payments
- Catalina Voinescu Santa Fe, NM Named on 227 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.